Screening for malignant cells in the blood and bone marrow was introduced as a strategy for the improved detection of tumour spread and may predict the development of distant metastases. The sensitivity of these approaches depends on several factors, including the choice of antibody for immunocytoch
Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation
β Scribed by Udo Bilkenroth; Helge Taubert; Dagmar Riemann; Udo Rebmann; Hans Heynemann; Axel Meye
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 333 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1217
No coin nor oath required. For personal study only.
β¦ Synopsis
We have established an immunomagnetic separation procedure for the detection of circulating tumor cells in the peripheral blood based on the magnetic cell sorting (MACS) technique. In previous in vitro experiments, renal-cell carcinoma (RCC) cells were mixed with peripheral blood. In dilutions of 1:200 to 1:10 7 tumor cells per mononuclear blood cells, an average recovery rate of 84% of tumor cells was determined. In our study, 104 peripheral blood samples from 59 renal carcinoma patients were analyzed. MACS resulted in significant depletion of leukocytes, permitting a search for tumor cells on just 1 slide. Analyzing 8 ml of peripheral blood per patient, 19/59 RCC patients carried disseminated tumor cells (32%) in the range of 1 to 38 cells (median 8). Interestingly, for the cytokeratin-positive (CK Ψ ) patient group, we found a correlation between tumor cell number and grading (G2 vs. G3) and an increased number of CK Ψ patients with advanced tumor stage. MACS appears to be an efficient technique to detect disseminated tumor cells in peripheral blood.
π SIMILAR VOLUMES
Immunocytochemical detection (ICC) of isolated tumor cells in bone marrow (BM) is currently the most established method for monitoring early dissemination in epithelial cancer. However, the low sample size that can practically be analyzed restricts the sensitivity and reliability of the ICC method.
Dendritic cells are considered to be the initiators of immune responses, including those directed against tumors. Clinical research on dendritic cells was long hampered by the limited availability of these cells. The recent identification of cytokine combinations that mobilize dendritic cells with p
## Abstract Detection of rare, circulating tumor cells (CTC's) in human peripheral blood is a potential indicator of prognosis and diagnosis in oncology. Typical methods to detect these CTC's are either by immunocytochemistry (ICCS) or RTβPCR. However without accurate, rapid, and reproducible enric
Melanoma and renal-cell carcinoma (RCC) are generally consided to be relatively immunogenic tumor types in humans. In the case of melanoma, many major histocompatibility complex (MHC) class I-restricted tumor-specific cytotoxic T lymphocytes (Cn) have been isolated from either tumorinfiltrating lymp